Rhythm Pharmaceuticals, Inc. (RYTM)
92.57
-0.50
(-0.54%)
USD |
NASDAQ |
Oct 30, 16:00
92.61
+0.04
(+0.04%)
After-Hours: 20:00
Rhythm Pharmaceuticals Free Cash Flow : -146.30M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -146.30M |
| March 31, 2026 | -160.46M |
| December 31, 2025 | -156.63M |
| September 30, 2025 | -149.13M |
| June 30, 2025 | -108.22M |
| March 31, 2025 | -113.99M |
| December 31, 2024 | -154.38M |
| September 30, 2024 | -164.92M |
| June 30, 2024 | -168.72M |
| March 31, 2024 | -181.61M |
| December 31, 2023 | -141.87M |
| September 30, 2023 | -146.49M |
| June 30, 2023 | -164.05M |
| March 31, 2023 | -164.95M |
| December 31, 2022 | -177.71M |
| September 30, 2022 | -189.25M |
| June 30, 2022 | -182.43M |
| March 31, 2022 | -171.65M |
| December 31, 2021 | -151.44M |
| September 30, 2021 | -135.10M |
| Date | Value |
|---|---|
| June 30, 2021 | -122.00M |
| March 31, 2021 | -119.64M |
| December 31, 2020 | -122.19M |
| September 30, 2020 | -125.21M |
| June 30, 2020 | -131.91M |
| March 31, 2020 | -130.04M |
| December 31, 2019 | -126.14M |
| September 30, 2019 | -115.29M |
| June 30, 2019 | -98.69M |
| March 31, 2019 | -83.32M |
| December 31, 2018 | -62.78M |
| September 30, 2018 | -49.34M |
| June 30, 2018 | -40.58M |
| March 31, 2018 | -34.23M |
| December 31, 2017 | -29.59M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| September 30, 2016 | -21.55M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | 725.08M |
| Cytokinetics, Inc. | -580.72M |
| Exelixis, Inc. | 1.172B |
| Ionis Pharmaceuticals, Inc. | -567.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.152M |
| Cash from Investing (Quarterly) | 14.01M |
| Cash from Financing (Quarterly) | -1.165M |
| Free Cash Flow Per Share (Quarterly) | -0.1334 |
| Free Cash Flow to Equity (Quarterly) | 108.08M |
| Free Cash Flow to Firm (Quarterly) | -4.571M |
| Free Cash Flow Yield | -2.34% |